Other

Mylan also owns Somerset Pharmaceuticals Inc., a proprietary research and development company located in Tampa, Florida. Somerset developed EMSAM^®, a transdermal patch for the treatment of major depressive disorder, currently marketed in the United States by Bristol-Myers Squibb.